IL6 and dry eye syndrome: Collectively, these systematically controlled and rigorously quantified findings clearly indicate that pharmacological inhibition of NF‐κB or IL‐6 signaling pathways partially restores epithelial proliferation, accelerates wound closure, and significantly improves nerve regeneration and sensory recovery under aqueous‐deficient dry eye conditions following corneal injury.